Nigeria partners China to expand radiotherapy capacity

Argentina’s federal government announced Tuesday that it will no longer fund hospital care for non-resident foreigners, implementing a policy change previously ordered by President Javier Milei. The decision, made by Milei’s administration, aims to reduce financial strain on the healthcare system by limiting free services to residents. According to officials, the move does not affect emergency care, which includes conditions such as cardiac arrest, heart attacks, strokes, severe trauma, massive hemorrhages, extensive burns, and obstetric, pediatric, or neonatal emergencies. These critical situations will continue to receive free treatment. The policy shift follows a broader ideological stance by Milei, a self-proclaimed “anarcho-capitalist” and a political ally of former U.S. President Donald Trump. He has consistently argued that the Argentine state should not extend benefits, such as free healthcare, to individuals who do not contribute taxes. His administration claims the change targets “medical tourism,” defined as individuals traveling to Argentina for treatment and then returning to their home countries. However, no specific figures were provided to quantify the extent of this practice. The Argentine health system operates primarily at the provincial level, with only certain regional hospitals under federal control. This structure means that the implementation of the new policy could vary significantly across different regions. Officials from Buenos Aires province, governed by the center-left Peronist party, expressed skepticism about the necessity of the policy. Nicolas Kreplak, the province’s health minister, stated that less than one percent of emergency room visits and hospitalizations involve non-residents, suggesting that the issue of overburdened healthcare facilities stems more from resource shortages than foreign patients. Milei’s critics argue that the policy reflects a broader strategy to cut public spending, potentially undermining essential healthcare services. They contend that reducing funding for non-residents could indirectly affect the quality of care available to all citizens. Despite these concerns, the administration maintains that the policy is necessary to ensure fiscal responsibility and prioritize domestic healthcare needs. In contrast, Nigeria has taken steps to enhance its cancer care capabilities through collaboration with China. The Nigerian government, led by Health Minister Iziaq Salako, announced a strategic partnership aimed at expanding radiotherapy capacity through technology transfer, professional training, and research. This initiative includes a cooperation agreement with LinaTech, a Chinese firm specializing in advanced radiation therapy solutions. The goal is to improve early detection, treatment, and overall cancer care in the country. Nigeria faces a significant cancer burden, with approximately 127,763 new cases and 79,542 deaths recorded in 2022. Breast, prostate, and cervical cancers account for over 40% of cancer-related fatalities. To address this, the government has launched several programs, including the National Initiative for Cancer Early Detection, Screening and Coordinated Access to Network Care (NICE-SCAN), and the Task Force for the Elimination of Cervical Cancer. Additionally, the HPV vaccine has been introduced into the national immunization program, reaching over 14 million girls aged nine to 14. The partnership with China is expected to include technical assistance, joint research, and academic exchanges. Nigeria seeks to establish a joint work plan with designated focal points and regular progress reviews. The initiative also aims to twin Nigerian cancer centers, such as the National Institute for Cancer Research and Treatment (NICRAT), with Chinese institutions. Furthermore, the government plans to create a clinical training base in Nigeria to serve as a regional hub for advanced radiotherapy education. Long-term objectives include developing local technical and human capacity to support the installation, maintenance, and eventual production of cancer technologies. The government emphasizes the importance of trained personnel, sustainable maintenance systems, and ongoing technical support alongside new equipment. By 2030, Nigeria aims to achieve technology transfer, local assembly, and servicing of radiotherapy and imaging equipment, along with collaborative clinical trials and research using cancer registries. Incentives such as zero-duty and zero-VAT policies are designed to encourage investment in local health manufacturing.